Boehringer Ingelheim completes $76-million expansionThe Georgia facility produces more than 150 vaccines for pets, poultry, and wildlife October 14, 2019 Sen. David Perdue (R-Ga.), left, toured Boehringer Ingelheim’s plant in Athens, Ga., this week. The company expanded its plant after a $76 million investment, doubling its capacity to manufacture pet vaccines. Boehringer Ingelheim has injected $76 million into expanding its manufacturing plant in Athens, Ga., allowing it to double the facility’s capacity to produce vaccines. “[This] announcement is representative of the growth and investment Boehringer Ingelheim is making around the U.S.,” says company president, Everett Hoekstra. “It also signals our commitment to a world in which no animal suffers from preventable disease.” Headquartered in Duluth, Ga., Boehringer Ingelheim’s U.S. Animal Health Business amped up its manufacturing capacity at several sites in recent years, both in Georgia and in St. Joseph, Mo., where the company has maintained operations for more than a century. Boehringer Ingelheim employs about 440 people in Athens. The site produces more than 150 vaccines for pets, poultry, and wildlife, which are sold in more than 80 countries.
SponsoredNew kidney care to keep their strength up.Prescription Diet k/d is NOW with ActivBiome+ Kidney Defense to activate the gut microbiome to reduce uremic toxins + Learn More
Suggested Veterinary Products Digicare CentralVUE CV10x Central Monitoring and Telemetry SystemDigicare’s CentralVUE™...Double Head Probe Wireless Mini UltrasoundThis Ultrasound Probe consists of two heads (you can select convex, linear, micro-convex, transvaginal), and is suited for multiple applications at the same time – All while costing less than...
SponsoredFeline urinary health—meet a simple solutionUrinary health is complicated, but the solution doesn’t have to be. Our products nutritionally support urinary tract and bladder health at any stage. + Recommend Today